Nodal promotes growth and invasion in human gliomas

Oncogene

Volumn 29, Issue 21, 2010, Pages 3110-3123

  Lee, C C ^a,b,c   Jan, H J ^d   Lai, J H ^d   Ma, H I ^e   Hueng, D Y ^e   Gladys Lee, Y C ^b   Cheng, Y Y ^d   Liu, L W ^d   Wei, H W ^f   Lee, H M ^d,g  

^a Shin Kong Memorial Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Glioma; Invasion; MMP 2; Nodal

Indexed keywords

CRIPTO 1 PROTEIN; GELATINASE A; GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; PROTEIN NODAL; RECOMBINANT PROTEIN; SMAD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GLIOMA; GLIOMA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; XENOGRAFT;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; GLIOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; SMAD PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

MUS;

EID: 77952954910     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.55     Document Type: Article

References (35)

1. Bennett JT, Stickney HL, Choi WY, Ciruna B, Talbot WS, Schier AF. (2007). Maternal nodal and zebrafish embryogenesis. Nature 450: E1-E2; discussion E2-4.
2. Besser D. (2004). Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279: 45076-45084.
3. Brennan J, Norris DP, Robertson EJ. (2002). Nodal activity in the node governs left-right asymmetry. Genes Dev 16: 2339-2344.
4. Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, Arias A et al. (2007). High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160.
5. Candolfi M, Curtin JF, Nichols WS, Muhammad AG, King GD, Pluhar GE et al. (2007). Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 85: 133-148.
6. Chakravarti A, Palanichamy K. (2008). Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. Cancer Treat Res 139: 173-189.
7. Christiansen JJ, Rajasekaran AK. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326.
8. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. (2007). Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255.
9. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ et al. (2004). SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3: 737-745.
10. Jan HJ, Lee CC, Shih YL, Hueng DY, Ma HI, Lai JH et al. (2010). Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro-Oncology 12: 58-70.
11. Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M et al. (2008). Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 27: 4830-4840.
12. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK et al. (2001). Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20: 6669-6678.
13. Ma HI, Guo P, Li J, Lin SZ, Chiang YH, Xiao X et al. (2002a). Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res 62: 756-763.
14. Ma HI, Lin SZ, Chiang YH, Li J, Chen SL, Tsao YP et al. (2002b). Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Therapy 9: 2-11.
15. Mancino M, Strizzi L, Wechselberger C, Watanabe K, Gonzales M, Hamada S et al. (2008). Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells. J Cell Physiol 215: 192-203.
16. Nonaka S, Shiratori H, Saijoh Y, Hamada H. (2002). Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 418: 96-99.
17. Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I et al. (2009). TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15: 315-327.
18. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
19. Postovit LM, Margaryan NV, Seftor EA, Hendrix MJ. (2008a). Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res 21: 348-357.
20. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW et al. (2008b). Human embryonic stem cell microenvironment suppresses the tumorigenic pheno-type of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329-4334.
21. Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ. (2000). The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82: 52-55.
22. Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K et al. (1997). Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87: 420-430.
23. Saha S, Ji L, de Pablo JJ, Palecek SP. (2008). TGFbeta/activin/Nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain. Biophys J 94: 4123-4133.
24. Smith JR, Vallier L, Lupo G, Alexander M, Harris WA, Pedersen RA. (2008). Inhibition of activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 313: 107-117.
25. Strizzi L, Hardy KM, Seftor EA, Costa FF, Kirschmann DA, Seftor RE et al. (2009). Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res 69: 7131-7134.
26. Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE et al. (2008). Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29: 91-103.
27. Strojnik T, Kavalar R, Lah TT. (2006). Experimental model and immuno-histochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res 26: 2887-2900.
28. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
29. Svechnikova I, Almqvist PM, Ekstrom TJ. (2008). HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. Int J Oncol 32: 821-827.
30. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925-932.
31. Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R et al. (2004). SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 64: 7954-7961.
32. Vallier L, Alexander M, Pedersen RA. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118: 4495-4509.
33. Vallier L, Reynolds D, Pedersen RA. (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroecto-dermal default pathway. Dev Biol 275: 403-421.
34. Wick W, Naumann U, Weller M. (2006). Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12: 341-349.
35. Zhou R, Skalli O. (2000). TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 254: 269-278.